Philip Campbell

Philip Campbell, M.D., Ph.D. is a psychiatrist-scientist interested in the cellular and molecular mechanisms of neurodevelopmental disorders. Using mutagenesis, behavioral phenotyping, and brain imaging approaches, he is studying the 22q11.2 deletion syndrome, a risk factor for multiple neurodevelopmental disorders including autism and schizophrenia, with the ultimate aim to identify novel molecular targets for therapeutic intervention.